- Home
- LNTH vs BDC Comparison
LNTH vs BDC Comparison
Compare LNTH & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | BDC |
|---|---|---|
| Founded | 1956 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.6B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LNTH | BDC |
|---|---|---|
| Price | $72.76 | $122.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $83.20 | ★ $148.33 |
| AVG Volume (30 Days) | ★ 875.1K | 337.9K |
| Earning Date | 05-25-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 0.16% |
| EPS Growth | N/A | ★ 23.13 |
| EPS | 3.41 | ★ 5.91 |
| Revenue | $343,374,000.00 | ★ $2,715,194,000.00 |
| Revenue This Year | N/A | $8.80 |
| Revenue Next Year | $13.47 | $4.67 |
| P/E Ratio | $21.33 | ★ $20.78 |
| Revenue Growth | 3.62 | ★ 10.33 |
| 52 Week Low | $47.27 | $83.18 |
| 52 Week High | $111.29 | $159.99 |
Technical Indicators
Market Signals| Indicator | LNTH | BDC |
|---|---|---|
| Relative Strength Index (RSI) | 52.23 | 33.42 |
| Support Level | $69.12 | $113.99 |
| Resistance Level | $73.72 | $125.01 |
| Average True Range (ATR) | 2.97 | 4.50 |
| MACD | 0.02 | -3.20 |
| Stochastic Oscillator | 29.18 | 1.74 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About BDC Belden Inc
Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.